comparemela.com


Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
- Novo Holdings created and built Muna Therapeutics with pioneers in the field of neurodegeneration
- Led by an experienced management team of Entrepreneurs-in-Residence from Novo Seeds
- Financing co-led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund, with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB
News provided by
Share this article
Share this article
COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ -- Novo Holdings, a global life science investor, today announces that it has co-led the Series A financing of its portfolio company, Muna Therapeutics ("Muna"), which is pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases. The financing also includes Sofinnova Partners, Droia Ventures and LSP Dementia Fund with participation from Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB.

Related Keywords

Denmark ,Copenhagen ,Køavn ,Simon Glerup ,Anders Hinsby ,Morten Graugaard ,Rita Balice Gordon ,Novo Nordisk ,Dementia Fund ,Partner At Novo Holdings ,Novo Group ,Polaris Innovation Fund ,Prnewswire Novo Holdings ,Novo Nordisk Foundation ,Novo Holdings ,Aarhus University ,Muna Therapeutics ,Sofinnova Partners ,Droia Ventures ,Polaris Partners ,Sanofi Ventures ,V Bio Ventures ,Professor Simon Glerup ,Enovo Seeds ,Novo Seed ,Professor Bart De Strooper ,Chief Executive Officer ,Frontotemporal Dementia ,Managing Partner ,Investigational New Drug ,டென்மார்க் ,கோபெந்ஹேகந் ,முதுமை நிதி ,கூட்டாளர் இல் நோவோ ஹோல்டிங்ஸ் ,நோவோ குழு ,நோவோ ஹோல்டிங்ஸ் ,ஆர்ஹஸ் பல்கலைக்கழகம் ,முனா சிகிச்சை ,போழரிச் கூட்டாளர்கள் ,சனோஃபி முயற்சிகள் ,வ் உயிர் முயற்சிகள் ,நோவோ விதைகள் ,நோவோ விதை ,தலைமை நிர்வாகி அதிகாரி ,நிர்வகித்தல் கூட்டாளர் ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.